DAYTON CLINICAL ONCOLOGY PROGRAM INC (EIN 311100389) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1983

Legal Domicile

Principal Officer

MARY ONTKO

Phone

9375282900

Tax Period

2024-06-01 to 2025-05-31

DAYTON CLINICAL ONCOLOGY PROGRAM INC, founded in 1983, is a small nonprofit in the Diseases & Disorders sector that reported $975K in total revenue in fiscal year 2024. Revenue decreased 5% compared to the prior year. Expenses of $1.1M exceeded revenue, resulting in a 17% operating deficit.

Mission

TO REDUCE CANCER INCIDENCE AND MORTALITY WITHIN THE LOCAL COMMUNITY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $857,551

Program Service Revenue $49,361

Investment Income $62,911

Other Revenue $4,802

TOTAL REVENUE $974,625

Expense Breakdown

Grants Paid $0

Salaries & Benefits $883,534

Fundraising Expenses $891

Program Expenses $1,024,770

Other Expenses $255,100

TOTAL EXPENSES $1,138,634

Year-over-Year Comparison

	2024	2023	Change
Revenue	$974,625	$1,029,621	-0.1%
Expenses	$1,138,634	$1,142,435	0.0%
Net Income	$-164,009	$-112,814	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$153,847

Total Directors

$109,672

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HOWARD M GROSS	CHAIRPERSON	1.50	Officer Director	$25,000	$0	$25,000
ROGER WOOD	VICE CHAIRPERSON	0.30	Officer Director	$0	$0	$0
ALISHA REISS	TRUSTEE	0.30	Director	$0	$0	$0
MICHELLE KINNEY	PRESIDENT/CEO	40.00	Officer Director	$84,672	$0	$84,672
ANDREA MOLINA	TRUSTEE	0.30	Director	$0	$0	$0
GILBERT PADULA	TRUSTEE	0.30	Director	$0	$0	$0
JULIE PRATT	TRUSTEE	0.30	Director	$0	$0	$0
AMY M MILLS	TRUSTEE	0.30	Director	$0	$0	$0
MARY ONTKO	INTERIM PRESIDENT/CEO	40.00	Officer	$44,175	$0	$44,175

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$974,625	$1,138,634	$2,961,723	$-164,009
2024	$1,029,621	$1,142,435	$3,080,790	$-112,814
2023	$1,111,956	$1,221,214	$3,198,697	$-109,258
2022	$1,120,839	$1,115,578	$2,853,577	$5,261
2021	$1,286,734	$1,043,661	$3,051,449	$243,073
2020	$1,278,660	$1,136,571	$2,811,152	$142,089
2019	$1,092,868	$1,161,169	$2,640,538	$-68,301

DAYTON CLINICAL ONCOLOGY PROGRAM INC